Sunshine Guojian Pharmaceutical (shanghai) Co., Ltd.

This study tests a new drug called 608 for people with active ankylosing spondylitis, a type of arthritis that causes back pain and stiffness. About 500 adults who did not get enough relief from standard pain relievers will receive either 608 or a placebo. The main goal is to see…

This study tests a new medicine called 611 in Chinese teenagers (ages 12-17) with moderate-to-severe atopic dermatitis (eczema). The drug targets a protein involved in inflammation to reduce skin redness, itching, and rashes. About 180 participants will receive either 611 or a pl…

This study tests a new medicine called SSGJ-626 for people with systemic lupus erythematosus (SLE), an autoimmune disease. The drug targets a protein on certain immune cells to try to control the disease. About 198 adults aged 18-70 with SLE will receive either the drug or a plac…

This study tests a new drug called 610 in Chinese adults with severe eosinophilic asthma. The goal is to see if it can reduce the number of serious asthma attacks over one year. Participants will receive either the drug or a placebo, and researchers will monitor their safety and …

This study tests a new medicine called 611 in Chinese adults with moderate to severe COPD. The goal is to see if 611 can reduce the number of serious lung attacks (exacerbations) and improve breathing. About 594 current or former smokers aged 40-85 will receive either 611 or a pl…